Clinical
Phase 4 Trial
Post-approval surveillance trials monitoring long-term safety in real-world use.
Definition
Phase 4 commitments are often required by the FDA as part of approval. They detect rare adverse events and confirm effectiveness in broader populations.
Related terms
Back to the full peptide glossary.